COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1415.4 | 4 | 0074-0156 | 501.76 | 155.35 | 336 | 70.67 | 0.845 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2732.9 | 4 | 0075-0157 | 85.02 | 157.84 | 241 | 57.94 | 0.902 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5511.5 | 4 | 0076-0158 | 632.22 | 157.63 | 165 | 47.70 | 0.911 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2814.4 | 4 | 0077-0159 | 100.79 | 159.94 | 187 | 50.63 | 0.917 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3448.2 | 4 | 0078-0160 | 656.24 | 160.82 | 256 | 62.77 | 0.816 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1052.9 | 4 | 0079-0170 | 22.33 | 169.11 | 241 | 60.28 | 0.833 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1845.0 | 4 | 0080-0178 | 791.21 | 178.94 | 515 | 84.91 | 0.898 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2155.1 | 4 | 0081-0181 | 448.03 | 180.50 | 247 | 63.26 | 0.776 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2328.2 | 4 | 0082-0182 | 233.32 | 181.46 | 300 | 68.18 | 0.811 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1495.6 | 4 | 0083-0180 | 310.78 | 180.92 | 232 | 56.28 | 0.920 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1995.5 | 4 | 0084-0185 | 70.87 | 183.78 | 239 | 60.77 | 0.813 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2377.3 | 4 | 0085-0186 | 549.29 | 186.57 | 365 | 70.67 | 0.918 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1189.5 | 4 | 0086-0189 | 897.78 | 188.80 | 401 | 76.08 | 0.871 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3075.4 | 4 | 0087-0189 | 670.54 | 188.33 | 240 | 58.53 | 0.880 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3897.2 | 4 | 0088-0192 | 286.83 | 192.36 | 336 | 70.08 | 0.860 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 4773.4 | 4 | 0089-0193 | 616.47 | 193.71 | 205 | 55.11 | 0.848 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2387.0 | 4 | 0090-0199 | 343.20 | 198.44 | 387 | 74.91 | 0.867 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1457.0 | 4 | 0091-0197 | 474.47 | 197.98 | 279 | 62.77 | 0.890 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5964.8 | 4 | 0092-0200 | 270.94 | 200.21 | 198 | 54.53 | 0.837 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3898.2 | 4 | 0093-0201 | 515.72 | 200.27 | 291 | 64.18 | 0.888 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 957.0 | 4 | 0094-0203 | 936.46 | 203.12 | 246 | 60.43 | 0.847 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 889.8 | 4 | 0095-0209 | 22.00 | 209.14 | 321 | 76.18 | 0.695 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 13874.3 | 4 | 0096-0205 | 578.42 | 204.94 | 380 | 71.36 | 0.938 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3420.9 | 4 | 0097-0203 | 380.38 | 202.68 | 222 | 56.28 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 4282.8 | 4 | 0098-0204 | 131.18 | 204.17 | 215 | 55.94 | 0.863 |